Niche Focus Small but specialized biostatistics and SAS programming firm serving pharma, biotech, medical devices, and CROs with expertise in SDTM/ADaM submissions and eCTD NDA/BLA support, indicating potential for long-term, high-value CRO partnerships.

Regulatory Readiness Deep regulatory experience across pre-clinical to phase III, NDA/BLA submissions and FDA inquiries suggests MPB Biostats can assist sponsor companies navigating complex regulatory pathways, a strong upsell opportunity for end-to-end submission support.

Global Standards All staff possess GCP training and SOP-driven workflows, plus openness to align with client SOPs, signaling reliable quality controls and easy onboarding for large clients seeking compliant biostatistical services.

Growth Readiness Revenue in the low-to-mid millions with a lean team indicates potential for scale through strategic partnerships, white-label arrangements, or expanded service lines to capture larger CROs and sponsor programs.

Tech Enablement Technology stack includes industry-standard web analytics and data tools; opportunities exist to upsell advanced data management, automation, and scalable reporting capabilities to improve efficiency for multicenter trials.